723 related articles for article (PubMed ID: 21323570)
1. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
Haasbach E; Droebner K; Vogel AB; Planz O
J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
3. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
[TBL] [Abstract][Full Text] [Related]
4. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses.
Li IW; Chan KH; To KW; Wong SS; Ho PL; Lau SK; Woo PC; Tsoi HW; Chan JF; Cheng VC; Zheng BJ; Chen H; Yuen KY
J Clin Virol; 2009 Dec; 46(4):325-30. PubMed ID: 19801200
[TBL] [Abstract][Full Text] [Related]
5. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells.
Zeng H; Goldsmith C; Thawatsupha P; Chittaganpitch M; Waicharoen S; Zaki S; Tumpey TM; Katz JM
J Virol; 2007 Nov; 81(22):12439-49. PubMed ID: 17855549
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
[TBL] [Abstract][Full Text] [Related]
7. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
[TBL] [Abstract][Full Text] [Related]
8. Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes.
Scagnolari C; Trombetti S; Soldà A; Selvaggi C; Monteleone K; Spano L; Pierangeli A; Clementi M; Turriziani O; Antonelli G
J Interferon Cytokine Res; 2011 Jun; 31(6):475-9. PubMed ID: 21235413
[TBL] [Abstract][Full Text] [Related]
9. Infection of human retinal pigment epithelial cells with influenza A viruses.
Michaelis M; Geiler J; Klassert D; Doerr HW; Cinatl J
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5419-25. PubMed ID: 19553611
[TBL] [Abstract][Full Text] [Related]
10. 2009 pandemic H1N1 influenza A virus strains display differential pathogenicity in C57BL/6J but not BALB/c mice.
Otte A; Gabriel G
Virulence; 2011; 2(6):563-6. PubMed ID: 22030859
[TBL] [Abstract][Full Text] [Related]
11. Early control of H5N1 influenza virus replication by the type I interferon response in mice.
Szretter KJ; Gangappa S; Belser JA; Zeng H; Chen H; Matsuoka Y; Sambhara S; Swayne DE; Tumpey TM; Katz JM
J Virol; 2009 Jun; 83(11):5825-34. PubMed ID: 19297490
[TBL] [Abstract][Full Text] [Related]
12. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
Viruses; 2017 May; 9(5):. PubMed ID: 28498306
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination.
Lin HT; Chuang CC; Wu HL; Chu DM; Wang YC
J Biomed Sci; 2013 Mar; 20(1):19. PubMed ID: 23517052
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.
Belser JA; Wadford DA; Pappas C; Gustin KM; Maines TR; Pearce MB; Zeng H; Swayne DE; Pantin-Jackwood M; Katz JM; Tumpey TM
J Virol; 2010 May; 84(9):4194-203. PubMed ID: 20181710
[TBL] [Abstract][Full Text] [Related]
15. Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice.
Li H; Bradley KC; Long JS; Frise R; Ashcroft JW; Hartgroves LC; Shelton H; Makris S; Johansson C; Cao B; Barclay WS
PLoS Pathog; 2018 Jan; 14(1):e1006821. PubMed ID: 29300777
[TBL] [Abstract][Full Text] [Related]
16. [Cytokine storm in avian influenza].
Us D
Mikrobiyol Bul; 2008 Apr; 42(2):365-80. PubMed ID: 18697437
[TBL] [Abstract][Full Text] [Related]
17. Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models.
Otte A; Sauter M; Alleva L; Baumgarte S; Klingel K; Gabriel G
Am J Pathol; 2011 Jul; 179(1):230-9. PubMed ID: 21703405
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.
Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H
Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921
[TBL] [Abstract][Full Text] [Related]
19. Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
Hatta Y; Hershberger K; Shinya K; Proll SC; Dubielzig RR; Hatta M; Katze MG; Kawaoka Y; Suresh M
PLoS Pathog; 2010 Oct; 6(10):e1001139. PubMed ID: 20949022
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
Lee SM; Gai WW; Cheung TK; Peiris JS
Antiviral Res; 2011 Sep; 91(3):330-4. PubMed ID: 21798291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
